Ocata Therapeutics Inc fka OCAT

[rocky301]

Steve,


At the end of 2010 ACT secured $25MM in funding from Socius.
http://www.advancedcell.com/news-and-media/press-releases/advanced-cell-technology-secures-25-million-funding-commitment/

This funding can be drawn down by ACT whenever it sees fit to do so. ACT has drawn down $4MM to date leaving 21MM available.

ACT/Socius contract requires registration of the ACT common shares to back up this loan commitment.

ACT filed a registration statement on 2-14-2011 for approx 224MM shares based on a .16 exercise price as that was the pps at the time of deal. This registration needs to be declared "effective" by the SEC in order for Socius to be able to sell shares they receive from ACT. The amendments you see filed are to update info and sometimes are updated because the SEC wants something explained or changed.